The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results.
 
Anna K. Nowak
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Epizyme; Merck Sharp & Dohme; Roche; Sellas Life Sciences; Trizell
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim
 
Willem Joost Lesterhuis
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - University of Western Australia (Inst)
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
 
Chris Brown
No Relationships to Disclose
 
Peey Sei Kok
No Relationships to Disclose
 
Kenneth John O'Byrne
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech; Teva
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Queensland University of Technology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
 
Tom John
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Ignyta; MSD Oncology; Novartis; Pfizer; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Ignyta; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Roche
 
Nick Pavlakis
Honoraria - Bayer; Boehringer Ingelheim; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
 
Steven Chuan-Hao Kao
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Sonia Yip
No Relationships to Disclose
 
Deme John Karikios
Honoraria - Pfizer
 
Wei-Sen Lam
No Relationships to Disclose
 
Ailsa Langford
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer